Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Other4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03696030Phase 1Active Not Recruiting
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
Breast CancerHER2-positive Breast CancerMalignant Neoplasm+2 more
PrincipalinvestigatorStart date: 2018-11-27
NCT02192359Phase 1Active Not Recruiting
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
Recurrent Anaplastic AstrocytomaRecurrent Anaplastic OligoastrocytomaRecurrent Anaplastic Oligodendroglioma+4 more
PrincipalinvestigatorStart date: 2016-04-05
NCT07791264Phase 1Not Yet Recruiting
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
GlioblastomaMalignant GliomaRecurrent Glioblastoma+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03696030Phase 1PrincipalInvestigator

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Breast CancerHER2-positive Breast CancerMalignant Neoplasm+2 more
Active Not Recruiting
NCT02192359Phase 1PrincipalInvestigator

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Recurrent Anaplastic AstrocytomaRecurrent Anaplastic OligoastrocytomaRecurrent Anaplastic Oligodendroglioma+4 more
Active Not Recruiting
NCT05773664Phase 1PrincipalInvestigator

Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma

GlioblastomaMalignant Glioma
Withdrawn
NCT07791264Phase 1PrincipalInvestigator

FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma

GlioblastomaMalignant GliomaRecurrent Glioblastoma+1 more
Not Yet Recruiting

All 4 trials loaded